glyxambi.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: https://www.glyxambi.com/sitemap.xml # Block pdf files. Disallow: /pdf/*.pdf$ Disallow: | ||
Meta Tags
| Title | Type 2 Diabetes Medication | Glyxambi (empagliflozin/linagliptin) |
| Description | Rethink the math when it comes to The empagliflozin and linagliptin combination once-daily pill, GLYXAMBI, helps lower a1c and blood sugar in adults with type 2 diabetes. Not for type 1 diabetes or diabetic ketoacidosis. Not studied in patients with history of |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.109.115 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
glyxambi.com Valuation
|
US$22,180,898
Last updated: 2023-05-07 14:49:27
glyxambi.com has Semrush global rank of 477,181. glyxambi.com has an estimated worth of US$ 22,180,898, based on its estimated Ads revenue. glyxambi.com receives approximately 2,559,335 unique visitors each day. Its web server is located in United States, with IP address 45.60.109.115. According to SiteAdvisor, glyxambi.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$22,180,898 |
| Daily Ads Revenue | US$20,475 |
| Monthly Ads Revenue | US$614,241 |
| Yearly Ads Revenue | US$7,370,883 |
| Daily Unique Visitors | 170,623 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| glyxambi.com. | A | 298 | IP: 45.60.109.115 |
| glyxambi.com. | A | 298 | IP: 45.60.73.115 |
| glyxambi.com. | NS | 3600 | NS Record: ns5.perf1.asia. |
| glyxambi.com. | NS | 3600 | NS Record: ns1.perf1.com. |
| glyxambi.com. | NS | 3600 | NS Record: ns3.perf1.eu. |
| glyxambi.com. | NS | 3600 | NS Record: ns4.perf1.de. |
| glyxambi.com. | NS | 3600 | NS Record: ns2.perf1.fr. |
| glyxambi.com. | TXT | 3600 | TXT Record: v=spf1 include:_spf.boehringer-ingelheim.com -all |
| glyxambi.com. | TXT | 3600 | TXT Record: facebook-domain-verification=uquu797cp7ny25dx67zmgioutamzq5 |
| glyxambi.com. | TXT | 3600 | TXT Record: google-site-verification=fHCzCLWCnD6GyQMdF7LzjOCMigEmD7-H7I0ODAVeNy4 |
| glyxambi.com. | TXT | 3600 | TXT Record: _globalsign-domain-verification=k_URN5sk-BJy4wlDWlaCtPxKZipt3rDs4F3YwltNmy |
HtmlToTextCheckTime:2023-05-07 14:49:27
| Prescribing Information Medication Guide Important Safety Information For Healthcare Professionals Home Why GLYXAMBI? Savings Adults with type 2 diabetes, along with diet and exercise Rethink the math when it comes to A1C GLYXAMBI can be used along with diet and exercise to improve blood sugar in adults with type 2 diabetes, and can be used in adults with type 2 diabetes who have known cardiovascular (CV) disease when empagliflozin (JARDIANCE), one of the medicines in GLYXAMBI, is needed to reduce the risk of cardiovascular death. 2 proven diabetes medications come together to help lower blood sugar Type 2 diabetes affects multiple parts of the body—maybe it’s time for a medication that works in multiple ways. GLYXAMBI combines the power of 2 proven diabetes medications—empagliflozin and linagliptin, working together to lower A1C, along with diet and exercise. And in adults with type 2 diabetes who have known cardiovascular disease, empagliflozin (JARDIANCE), one of the medicines in |
HTTP Headers
HTTP/1.1 301 Moved Permanently
Location: https://glyxambi.com/
Content-Length: 0
Connection: close
HTTP/1.1 301 Moved Permanently
Date: Thu, 28 Oct 2021 06:27:12 GMT
Content-Type: text/html
Content-Length: 166
Connection: keep-alive
Location: http://www.glyxambi.com/
X-LAGOON: bi2.amazee.io>glyxambi-com-master:nginx>nginx-b958bb99d-f6hkd
Set-Cookie: visid_incap_2283979=DbgoVZbKS8uv/6Lqz/tW7r9CemEAAAAAQUIPAAAAAADBuykxcQCylTqweDVkfYly; expires=Thu, 27 Oct 2022 10:11:08 GMT; HttpOnly; path=/; Domain=.glyxambi.com
Set-Cookie: nlbi_2283979=/6awDK32/kHZVEM8xIh/JAAAAACGw1Y87MqYIC1VyuDuEr/c; path=/; Domain=.glyxambi.com
Set-Cookie: incap_ses_1227_2283979=ilbmeyIaNmr+ASvwVS4HEb9CemEAAAAAU8diUoZIA5ZfLJ58WyA0KA==; path=/; Domain=.glyxambi.com
Set-Cookie: ___utmvmvOBuvEyIZ=JCNbQJRLmEW; path=/; Max-Age=900
Set-Cookie: ___utmvavOBuvEyIZ=tbJXwWT; path=/; Max-Age=900
Set-Cookie: ___utmvbvOBuvEyIZ=gZM
XBPOxalu: ItQ; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 13-170961424-170961448 NNNN CT(91 97 0) RT(1635402431661 42) q(0 0 1 4) r(2 2) U6
HTTP/1.1 301 Moved Permanently
Location: https://www.glyxambi.com/
Content-Length: 0
Connection: close
HTTP/1.1 200 OK
Date: Thu, 28 Oct 2021 06:27:13 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Cache-Control: no-cache, private
X-Frame-Options: DENY
Set-Cookie: XSRF-TOKEN=eyJpdiI6IklcL1dPNkJoOEtkUHdnNzZiZWZ6ZXlBPT0iLCJ2YWx1ZSI6ImROWXhjcGNFQ0pIazV3Z0RvMEdQUXN0a1wvaGtrcVMrMVRlbHlwaHFwNXFFNDVhWUVhNnpEZFlad0NDam5ZSWg0IiwibWFjIjoiNDY1ZmY1MWFlY2E1ZmRkZGU2NjhlMDE5MTcwZGE4ZTIzN2RkMjRmMDRjZWRmZjU5ZjE0MzQyNDA4N2ZjYTAxMCJ9; expires=Thu, 28-Oct-2021 08:27:13 GMT; Max-Age=7200; path=/; secure; httponly; samesite=lax
Set-Cookie: laravel_session=eyJpdiI6ImZPcjNXWkhtOFozaFFEakljRXZRc1E9PSIsInZhbHVlIjoiVG5yZVI1NTl4TU53ZUNDYVdzU1BiamNGMTJcLytSV2xoSHFKYlJFVlwvTTcraXI0RGcxNWN3cHZGVTNXN3hRUW13IiwibWFjIjoiNWVlMzNiMzA1ODlkNDljNDExN2EwODU1Mjk5ZDhlNTg2N2ViMTU0YmE4NWEzNmVjYWUwNzVjZGRkYWE1MzBiOCJ9; expires=Thu, 28-Oct-2021 08:27:13 GMT; Max-Age=7200; path=/; secure; httponly; samesite=lax
X-LAGOON: bi2.amazee.io>glyxambi-com-master:nginx>nginx-b958bb99d-f6hkd
Set-Cookie: visid_incap_2283979=e76Y+6UZRy+GMQGT0jYylMBCemEAAAAAQUIPAAAAAADto4TfGR9ucXV4qj6QQb0E; expires=Thu, 27 Oct 2022 09:32:10 GMT; HttpOnly; path=/; Domain=.glyxambi.com
Set-Cookie: nlbi_2283979=CTWgURiRwGyaxcIixIh/JAAAAADWQj3IIzolgtzcH+WSqWkO; path=/; Domain=.glyxambi.com
Set-Cookie: incap_ses_8215_2283979=kgb1fF0EHhLpK2jTSIsBcsBCemEAAAAA9SoyBOjs+kK3mBNSQe8HDw==; path=/; Domain=.glyxambi.com
Set-Cookie: ___utmvmzLYuvEyIZ=GwJUMZDeBUI; path=/; Max-Age=900
Set-Cookie: ___utmvazLYuvEyIZ=QVKLAWh; path=/; Max-Age=900
Set-Cookie: ___utmvbzLYuvEyIZ=iZT
XGaONalZ: NtP; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 14-161563206-161563208 NNNN CT(103 108 0) RT(1635402432603 16) q(0 0 2 1) r(3 3) U6
|
glyxambi.com Whois Information
Domain Name: GLYXAMBI.COM Registry Domain ID: 1837073189_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.nameshield.net Registrar URL: http://www.nameshield.net Updated Date: 2020-11-12T09:20:24Z Creation Date: 2013-11-27T19:02:00Z Registry Expiry Date: 2022-11-27T19:02:00Z Registrar: NAMESHIELD SAS Registrar IANA ID: 1251 Registrar Abuse Contact Email: abuse@nameshield.net Registrar Abuse Contact Phone: +33241182828 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.PERF1.COM Name Server: NS2.PERF1.FR Name Server: NS3.PERF1.EU Name Server: NS4.PERF1.DE Name Server: NS5.PERF1.ASIA DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T23:44:57Z <<< |